AVITA Medical, Inc. (RCEL) Upgraded to Buy at BTIG

Market Context

AVITA Medical, Inc. operates in the Healthcare sector. The stock currently trades at $7.77 with a market capitalization of $94.5M. The stock has gained 82.8% over the past 52 weeks.

Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. BTIG's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for AVITA Medical, Inc.

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 07, 2026	BTIG	Buy	N/A
May 15, 2026	Lake Street	Buy	N/A
Apr 09, 2026	D. Boral Capital	Buy	N/A
Apr 08, 2026	D. Boral Capital	Buy	N/A
Mar 05, 2026	Northland Capital Markets	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View RCEL Stock Page